Canadian-made Drugs for Rwanda: The First Application of the WTO Waiver on Patents and Medicines
On July 17, 2007, Rwanda notified the World Trade Organization's (WTO) Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) that it plans to import the HIV-drug TriAvir from the Canadian company Apotex and will not enforce any patents granted in that respect in Rwanda.[1] Two months later, Canada issued a compulsory license allowing Apotex to use nine patented inventions for manufacturing and exporting TriAvir to Rwanda.

In a 94-page judgment issued October 8, 2007, the International Court of Justice (ICJ or Court) found unanimously that Honduras, not Nicaragua, has sovereignty over four disputed islands in the Caribbean Sea.